Financial Architects, Inc Amarin Corp Plcuk Transaction History

Financial Architects, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $102,501 - $129,213	-6,300 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$12.61 - $22.33 $79,443 - $140,679	6,300 New	6,300 $131,000
Q1 2019 May 03, 2019	SELL	$12.61 - $22.33 $45,396 - $80,388	-3,600 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$12.41 - $22.98 $35,989 - $66,642	-2,900 Reduced 44.62%	3,600 $49,000
Q3 2018 Oct 29, 2018	SELL	$2.45 - $16.27 $8,575 - $56,945	-3,500 Reduced 35.0%	6,500 $106,000
Q3 2017 Nov 01, 2017	BUY	$3.03 - $3.72 $30,299 - $37,200	10,000	10,000 $35,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.